LY4005130

LY4005130 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY4005130, covering 2025-11-10 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) [Phase 2]